AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05084209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parkinson's medical decision making support
Description: Participants will be asked to view and work through medical decision making support resources. The resources will include information on medical decisions that may occur in Parkinson's disease, and general medical decisions that anyone may need to make (i.e. choosing a medical decision maker). The resources will also include suggestions on how to discuss these decisions.
Study NCT06536816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Game Profile-based training Group
Description: Game profile-based training is a methodology in sports, including football, where training sessions are designed to simulate the specific conditions and challenges that players face during actual games. Coaches analyze individual and team performance data to identify patterns, positions, and scenarios commonly encountered in matches. The training is then structured to replicate these situations, helping players develop the skills, tactics, and decision-making abilities required in real-game scenarios. This approach aims to make training more targeted and relevant to the dynamics of competitive play.
Study NCT06536816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Small-sided games Group
Description: small-sided game in football, often referred to as a SSG, is a practice or training activity where players compete in a reduced playing area with fewer players than a full team.
Study NCT06536816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined training Group with both Game Profile-based training and Small-sided Games
Description: Combined training Group with both Game Profile-based training and Small-sided Games
Study NCT06386471 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole grain rye bread
Description: Single consumption of 4.3 oz of whole grain rye bread
Study NCT06386471 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Refined grain rye bread
Description: Single consumption of 4.3 oz of refined grain rye bread
Study NCT04475744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF treatment for Bone marrow derived stem cell Mobilization
Description: Mobilization treatment. On the fifth day, collection will be started.
Study NCT04475744 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma ovarian injection
Description: Mobilized peripheral blood will be obtained to prepare the PRP for injection. Both ovaries will be injected when proper anatomical access can be assessed.
Study NCT04771169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vestibular Training Group
Description: this Group will receive vestibular Adaptation \& Balance exercises
Study NCT04771169 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Group
Description: This Group will receive Virtual Reality Training by using exergaming.
Study NCT05610553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D printing guide plate
Description: 3D-printed customized guide plate will be used to guide the puncture in percutaneous disc decompression surgeries to help to reduce intra-operative radiation, puncture time, etc..
Study NCT05610553 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional guidance
Description: The surgeons would place the needle according to his/her previous experience under the guidance of C-arm fluoroscopy or CT.
Study NCT05450432 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ketamine
Description: Study participants will start treatment including two ketamine infusion visits per week during the acute phase, for up to eight ketamine infusion visits. Participants will then be transitioned to maintenance with intranasal esketamine.
Study NCT05450432 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Esketamine
Description: After one month from the eighth ketamine infusion visit, participants will initiate weekly esketamine for 12 weeks, for a total of 13 esketamine treatments. The esketamine visits will happen as per standard of care at the clinic and as instructed by the SPRAVATO Risk Evaluation and Mitigation Strategy.
Study NCT05034692 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total laparoscopic with intracorporeal anastomosis by overlap method
Description: After the intestinal canal was dissociated and vascularized, the intestinal canal was nuded and cut off, and the distal and proximal intestinal canals were overlapped by 6 cm
Study NCT05034692 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic-assisted colectomy with extracorporeal anastomosis
Description: After the corresponding colon and blood vessels were dissociated and treated, the carbon dioxide pneumoperitoneum was removed. The appropriate length of the incision was cut at the corresponding position of the abdomen, and the incision protector was placed. The tumor was lifted together with the free intestinal canal to the outside of the abdomen. The intestinal canals at the quasi-dismembered sites on both sides of the tumor were nuded, and the colon-colon functional end-to-end anastomosis was performed.
Study NCT04937569 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Tablets
Description: 4-days course of Ivermectin 400 microgram/kg body weight maximum 4 tablets (6mg / tablet) once daily dose before breakfast
Study NCT04937569 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ivermectin Tablets
Description: 4-days course of Ivermectin 400 microgram/kg body weight maximum 4 tablets (6mg / tablet) once daily dose before breakfast
Study NCT05369234 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 100% Aloe Vera Juice
Description: George's 100% Aloe Vera Liquid Supplement
Study NCT05369234 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Magic Mouthwash
Description: Magic Mouthwash
Study NCT05369234 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Magic Mouthwash
Description: Magic Mouthwash
Study NCT05369234 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda
Study NCT05369234 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Salt and Baking soda rinse
Description: Mouth rinse made with salt and baking soda
Study NCT05369234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carafate
Description: Carafate taken as a slurry
Study NCT05369234 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carafate
Description: Carafate taken as a slurry
Study NCT06307678 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Hydroxide
Description: The samples were taken from the interstitial fluid of the apical tissues using 3 paper points before medicament placement.~Calcium hydroxide based medicament was placed in the canals using a file at a distance of 1 or 2 mm less than the root canal length.~At the second appointment, medicamentswere removed, and second samplingwas performed using the same method.~The RANKL/OPG, TNF alpha, TGF beta, PGE2 levels were measured by the enzyme-linked immunosorbent assay, and their ratio was calculated.
Study NCT06307678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Silicate
Description: The samples were taken from the interstitial fluid of the apical tissues using 3 paper points before medicament placement.~Calcium silicate based medicament was placed in the canals using a file at a distance of 1 or 2 mm less than the root canal length. At the second appointment, medicaments were removed, and second sampling was performed using the same method.~The RANKL/OPG, TNF alpha, TGF beta, PGE2 levels were measured by the enzyme-linked immunosorbent assay, and their ratio was calculated.
Study NCT05001399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Holographic Memory Resolution® (HMR)
Description: Clients will participate in Holographic Memory Resolution® (HMR) administered by a trained HMR practitioner. Clients will be introduced to relaxation techniques and safe scene identification. This exercise encourages the client to identify a place in which they feel safe and where nobody can be there without client's invitation. Clients will then describe the place and associated colors of the experience, how the colors move in their body, and how they move through their safe scene. The subsequent 2-3 sessions will continue to explore safe scene and color therapy.
Study NCT04099082 — intervention group
Intervention type: OTHER
Intervention: samples
Description: blood sample nasal swab
Study NCT05248269 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation
Description: The 2 pertinent contacts connect to Radiofrequency thermocoagulation lesion-generator equipment (Cosman G4 with Ad-tech electrodes), expressly modified for use with SEEG electrodes. The following parameters will be adopted: current power 3 W within 180 seconds and current intensity (usually approximately 25 mA) variable according to impedance.
Study NCT00935896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low tidal volume
Description: twenty patients were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of > 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4).
Study NCT00935896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low tidal volume
Description: Immediately after ICU admission, once all inclusion and exclusion criteria were met and consent obtained, twenty patients (16 men, 4 women, median age of 49 yrs) were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of > 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4)
Study NCT00935896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low tidal volume
Description: tidal volume of 5-7 ml/kg predicted body weight
Study NCT05124808 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive glycemic targets
Description: Fasting blood glucose \<90 mg/dL, 1 hour post-prandial blood glucose \<120 mg/dL
Study NCT05124808 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard glycemic targets
Description: Fasting blood glucose \<95 mg/dL, 1 hour post-prandial blood glucose \<140 mg/dL
Study NCT06189196 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BLOW BOTTLE
Description: Blow Bottle PEP' is the cost-effective device comparative to other PEP devices. Treatment (CPT) along with BBPEP twice a day. Therapist made a cost-effective BBPEP which generates 10 cm of H2O PEP and it was given for 10 breaths, 3 sets with 5 second hold.
Study NCT06189196 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACBT
Description: Active cycle of breathing technique (ACBT) is an alternative airway clearance technique. A typical ACBT cycle consists of breathing control, three to four thoracic expansion exercises, and a forced expiratory technique (huffing). ACBT has been shown to improve short-term secretion clearance in patients with chronic lung disease. It is also flexible, tolerated, and accepted well by patients. Although ACBT is widely used in patients with respiratory conditions characterized by chronic sputum production.
Study NCT05285696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSB-111
Description: \[68Ga\]-NOTA-hGZP is a PET imaging agent.
Study NCT06231225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentive Spirometer respiratory training
Description: The incentive spirometer is a handheld mechanical breathing device that uses a one-way valve to prevent exhalation. It consists of a corrugated tube and a nozzle connected to three consecutive plastic chambers, each containing a ball. The external chambers are marked with the minimum flow required to raise the ball internally. The ball rises when the patient performs slow, deep breathing through the nozzle. If the patient breathes too quickly, the balls in the chambers rise to the top, and if breathing is too slow, the balls fall to the bottom. The number of increasing balls measures the volume of inhaled air. When all three balls reach the top of the chambers, the patient's flow rate can reach 1200 ml/s. After the patient has maximized their inhalation, they are asked to hold the balls in the same position for more than 3 sec.
Study NCT06271837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Description: Trastuzumab deruxtecan by intravenous infusion
Study NCT06271837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab by intravenous infusion
Study NCT06365580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kylo-0603 capsule
Description: Administrated orally.
Study NCT05384327 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interview
Description: Interviews consist of semi-structured interviews focused on the theoretical knowledge a physician should possess before placing chest tube insertions.
Study NCT05384327 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Multiple Choice Question (MCQ) Test
Description: The test contains multiple choice questions based on these interviews. Participants will complete this test.~Validity evidence will be collected based on the results of this test.
Study NCT05178043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 240mg to be administered as an intravenous (IV) infusion every 2 weeks (Q2W).
Study NCT05178043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GT90001
Description: GT90001 7mg/kg to be administered as an intravenous infusion every 2 weeks (Q2W) after Nivolumab infusion.
Study NCT05940688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health intervention
Description: Health care information delivered via a link in a text message that is then opened in a secure browser.
Study NCT05940688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: Health care information delivered via CHW.
Study NCT05940688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health Intervention plus Community Health Worker
Description: Health care information delivered via DHI plus CHW
Study NCT03648398 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: EDUMICILOR
Description: Patients will participate in the online therapeutic education program for about 6 months
Study NCT06317363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Base Line + ACEPELLA
Description: Group A (baseline treatment + acapella) consisting of 15 participants will receive (baseline treatment aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition to using Acapella). The primary and secondary outcome measures will be assessed at baseline post-op day 1, and after 1 week of surgery.
Study NCT06317363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Base Line + Manual Chest Physiotherapy
Description: The group B consisting of 15 participants will receive base line treatment. aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition chest physiotherapy percussing for 20 minute. The s primary and secondary outcome measures will be assessed at baseline post-op day 1, and after 1 week of surgery.
Study NCT06018246 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Malnutrition five-step treatment model + conventional nutritional intervention
Description: 1. Before operation：Same as arm description.~2. After operation:Same as control group.~3. Out-of-hospital: Same as before operation.~4. Strengthening Health Education and psychological intervention:Dietitians need to strengthen health education and communicate with patients during the implementation of nutrition intervention.For patients who actively cooperate with treatment, dietitians can give encouragement.~5. Exercise Instruction:After the operation, according to the tolerance, the dietitian can instruct the patient to take a certain time walking every day, gradually increase the patient's muscle endurance and improve the body resistance.
Study NCT06018246 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional nutritional intervention
Description: Routine nutrition support in department.Nutritionists will give patients routine parenteral nutrition support via peripheral or central vein 0-48 hours after surgery and then start enteral nutrition support 48-72 hours after surgery.Patients were initially given half of their enteral nutrition and the rest was supplemented with parenteral nutrition.After adaptation, the patient stopped parenteral nutrition and all nutrition came from enteral nutrition.After the patient's gastrointestinal function gradually recovered, the enteral nutrition could gradually decrease.At this time, nutritionists can let the patient eat some light liquid food, but pay attention to eating a small amount of multiple times.After adaptation, patients can gradually transition from liquid diet to semi-liquid diet.We will educate patients and their families about diet and encourage them to eat more high-quality protein-rich foods.
Study NCT06563453 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial alternating current stimulation
Description: Transcranial Alternating Current Stimulation (tACS) is a tool that administers a weak alternating current (in the range of 0.1 to 4 mA), most often with a sinusoidal waveform, between electrodes placed over target areas. This can entrain the subjacent neuronal networks favouring the firing at specific frequencies of interest, in certain cases, with effects outlasting the stimulation duration up to 70 min.
Study NCT06563453 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial alternating current stimulation
Description: Transcranial Alternating Current Stimulation (tACS) is a tool that administers a weak alternating current (in the range of 0.1 to 4 mA), most often with a sinusoidal waveform, between electrodes placed over target areas. This can entrain the subjacent neuronal networks favouring the firing at specific frequencies of interest, in certain cases, with effects outlasting the stimulation duration up to 70 min.
Study NCT06323681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon α-2b based treatment group
Description: Peginterferon α-2b injection, 180mcg, s.c, once a week, for 48 weeks. If the baseline HBV DNA is higher than the minimum detection limit (using high-sensitivity kit), combined with nucleos(t)ide analogs (NAs) is recommended.
Study NCT06323681 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NAs monotherapy group
Description: First-line NAs (e.g. Entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), tenofovir amibufenamide (TMF)), one tablet a day, take orally, for 48 weeks.
Study NCT06472375 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: holter
Description: ambulant heart rate monitor (holter) for 24 hour.
Study NCT06542783 — intervention group
Intervention type: BEHAVIORAL
Intervention: referring to the results of AI model output
Description: determining the ANA pattern type with or without referring to the results of AI model output.
Study NCT05218031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: A 90-120 minute 5-week group intervention for unaccompanied minors. Each week there will be a different focus. Week 1: Grounding, Week 2: Unhooking, Week 3: Values, Week 4: Self-compassion, Week 5: Making room for unwanted thoughts and feelings.
Study NCT06420401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: araboxylan
Description: During the study period, subjects are instructed to take one pocket of arabosylan per day during the first week, followed by two pockets of araboxylan per day during the remianing 11 weeks. Aside from the dietary supplement provided, all participants are instructed to continue their normal routine and not make any changes to their dietary habits or physical activity.
Study NCT06420401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: inulin
Description: During the study period, subjects are instructed to take one pocket of inulin per day during the first week, followed by two pockets of inulin per day during the remianing 11 weeks. Aside from the dietary supplement provided, all participants are instructed to continue their normal routine and not make any changes to their dietary habits or physical activity.
Study NCT06420401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: inulin and araboxylan
Description: During the study period, subjects are instructed to take one pocket of inulin and araboxylan per day during the first week, followed by two pockets of inulin and araboxylan per day during the remianing 11 weeks. Aside from the dietary supplement provided, all participants are instructed to continue their normal routine and not make any changes to their dietary habits or physical activity.